Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Feb
8
2022
US Federal Labor Viewpoints – Week of February 5, 2022 Squire Patton Boggs (US) LLP
Mar
1
2022
Two Food Standards Agency (FSA) Food Law Consultations Opened – Novel Foods and Precautionary Allergen Labelling Squire Patton Boggs (US) LLP
Sep
26
2019
Opioid Update: 6th Circuit Orders Mandamus Response from Judge Polster, Bellwether Counties Squire Patton Boggs (US) LLP
Nov
30
2015
Pending FDA Rule Governing Transportation of Human and Animal Food (Or, Keep it Cold) (Or, Greater Regulation of the Cold Chain Anticipated) Squire Patton Boggs (US) LLP
Jan
2
2024
US State Law Roundup – 2023 Year-end Update Squire Patton Boggs (US) LLP
May
21
2020
Court Refuses to Enforce “Time-Traveling” Arbitration Clause Squire Patton Boggs (US) LLP
Jun
11
2020
Even If the Federal Circuit Could Award Attorney Fees for IPR Appeals, § 285 Does Not Permit It Award Fees Incurred During the IPR Squire Patton Boggs (US) LLP
Jul
21
2020
Senators Announce Bipartisan Bill Requiring Pharmaceutical Supply Chain Report Squire Patton Boggs (US) LLP
Dec
17
2020
FTC Cracks Down on Health Claims by CBD Companies Squire Patton Boggs (US) LLP
Aug
9
2017
Liquor Licences for Insolvency Practitioners: Recent Developments Squire Patton Boggs (US) LLP
Jan
8
2018
The Business of Cannabis – Getting into the Weeds Squire Patton Boggs (US) LLP
Jun
19
2018
US EPA Releases Problem Formulation Documents for “First Ten” TSCA Risk Evaluations Squire Patton Boggs (US) LLP
Nov
29
2021
Judge Blocks Portions of Centers for Medicare and Medicaid Services (CMS) Vaccine Mandate (US) Squire Patton Boggs (US) LLP
Sep
24
2018
Senate Overwhelmingly Clears Bipartisan Opioid Package Squire Patton Boggs (US) LLP
Apr
5
2019
Ohio Workers’ Compensation System Does Its Part to Mitigate the Opioid Epidemic’s Impact on the State’s Workforce (US) Squire Patton Boggs (US) LLP
May
28
2019
US EPA Extends Date For Designation of Inactive Substances on the TSCA Inventory to August 5, 2019 Squire Patton Boggs (US) LLP
Feb
11
2015
Senate Takes Shot At Vaccine-Preventable Diseases; Health Cybersecurity Examined; GAO Reports On ICD-10 Squire Patton Boggs (US) LLP
Jul
17
2019
HHS Abandons Proposal to Reform Drug Manufacturer Rebate System Squire Patton Boggs (US) LLP
Jan
31
2023
Bankruptcy Court Doors Swing Open For Cannabis Companies, But Just Slightly Squire Patton Boggs (US) LLP
Aug
26
2015
Litigation Fallout From All This Supply Chain Transparency Legislation (Or, These Things Have Teeth!) (Or, The Cycle of Misfortune) Squire Patton Boggs (US) LLP
Nov
24
2015
Legal Developments in EU Food and Beverage Sector Squire Patton Boggs (US) LLP
May
12
2016
Brexit – What are Implications for UK Chemical Regulatory Law and Policy? Squire Patton Boggs (US) LLP
Nov
8
2023
Ohio Legalizes Recreational Marijuana, But Employers’ Ability to Enforce Workplace Drug Policies Remains Intact (US) Squire Patton Boggs (US) LLP
Sep
9
2016
No Changes for Ohio Employers under the State’s New Medical Marijuana Law Squire Patton Boggs (US) LLP
Jan
2
2024
New U.S. Action Against Wine Bottle Imports Squire Patton Boggs (US) LLP
Nov
14
2016
Federal Nutrition Programs: SNAP, WIC Discussed in Congress This Week Squire Patton Boggs (US) LLP
Dec
8
2016
Cannabis Conundrum: Hurdles to Trademark Protection in a “Growing” Industry Squire Patton Boggs (US) LLP
Jul
28
2020
CBD: Sometimes It Can Be Legal but Still “Unlawful” Squire Patton Boggs (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins